Marc Goodman Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
46%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Specialty Retail
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $42 |
79%
upside
| 1 | +3.1% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Outperform
Initiated
| $75 |
11%
upside
| 1 | +26% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $205 |
10%
upside
| 1 | -15% |
0
%
| 28 Jan ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $8 |
256%
upside
| 1 | +34% |
0
%
| 12 Jan ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $30 |
1%
upside
| 1 | +51% |
0
%
| 21 Nov ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $5 |
92%
upside
| 1 | +48% |
0
%
| 17 Nov ‘25 5 months ago |
|
|
|
Market Perform
Downgraded
| $18.50 |
15%
downside
| 1 | – |
–
| 23 Oct ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $34 |
11%
upside
| 1 | +81% |
0
%
| 6 Oct ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $50 |
406%
upside
| 1 | -28% |
0
%
| 12 Aug ‘25 8 months ago |
|
|
|
Outperform
Upgraded
| $10 |
41%
downside
| 1 | +217% |
0
%
| 7 May ‘25 11 months ago |
|